Expertise

We know what you need, because we’ve done it before – more than once, and with proven results.

Neuroscios

Your Trusted Partner

“Choosing the right partner for your neurological clinical trials makes all the difference. At Neuroscios, we know the challenges in neurological drug development, and we’re here to help you navigate them with smart trial designs, strong recruitment strategies, and therapeutic area insights.

With us, you get a team that’s hands-on, responsive, and dedicated to your success. Let’s work together to bring better treatments to the people who need them most.”

Casper Clemmensen, Chief Commercial Officer

Explore Neuroscios

Clinical Research & Trial Capabilities

Neurological disorders require specialized trial designs to address complex disease mechanisms, biomarker-driven endpoints, and patient variability. At Neuroscios, we provide full-service clinical trial expertise, ensuring high-quality execution and regulatory success.

Expertise in Neurological Disorders

At Neuroscios, we only have a single focus for our clinical research: Neurological disorders. Our deep understanding of neurological disease mechanisms ensures optimized trial design and execution navigating the complexity.

Tailored Study Designs

We provide end-to-end protocol development, endpoint selection, and regulatory submissions (IND/CTA) to meet FDA, EMA, and global compliance requirements. Our expertise ensures trials are structured for efficiency and high data quality.

Global Recruitment Strategy

With access to a global network of research sites specialized in neurological disorders, patient registries, and Key Opinion Leaders in the field, we facilitate rapid enrollment, high patient retention, and high-quality data collection.

Seamless Trial Execution

From early-phase trials to late-stage studies, we manage project oversight, site monitoring, data analysis, and pharmacovigilance – leveraging advanced methodologies to enhance precision, optimize patient stratification, and ensure efficient trial conduct and operational success.

Neuroimaging

Radiologic imaging is playing an increasingly central role in neuroscience trials, with endpoints often tied to MRI, PET, or CT – even when not listed as primary. Regulatory agencies are now routinely requiring imaging to support screening, safety, and biomarker assessments.

Neuroscios brings over 13 years of experience in multi-site imaging standardization. We ensure consistent, unbiased results through rigorous imaging protocols, central reading, and oversight of all imaging activities.

Our services include:

Imaging protocol consultancy
Site training (technologists and radiologists)
Image collection, quality control, and central reading
Multi-vendor management and third-party oversight
Imaging data export and statistical analysis support

Cognitive Testing

Alzheimer’s and cognitive disorder drug development has faced persistent setbacks, often due to a mismatch between preclinical models and clinical assessment tools. Promising Phase II results frequently fail to translate into proven clinical efficacy.

A key issue: early trials often rely on unsuitable cognitive tests. Translating animal data – like spatial memory performance in the Morris water maze – into meaningful human outcomes requires more than simple substitution.

With 50+ years of combined experience in neurological disorders, we help you design smarter, more targeted studies.

We support with:

Therapeutic Focus

With a single focus on neurological disorders, we apply deep therapeutic knowledge to advance clinical research across CNS and neurogenerative conditions.

Scientific Leadership

With 30+ years in Neuroscience, our scientific leadership contains eminent authorities in the field – combining scientific expertise with operational excellence.

Real Impact

Our scientific precision and clinical research play a key role in advancing treatments for neurological disorders, making a real impact on patients’ lives.

Years in Neuroscience

0 +

Alzheimer's Trials

0 +

Phase I Trials

0 %